VBI Vaccines, Inc.

VBI Vaccines, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. VBI Vaccines, Inc. is not a good value stock. VBI Vaccines, Inc. is not very popular among insiders. VBI Vaccines, Inc. is a mediocre stock to choose.

VBI Vaccines, Inc. operates as a biopharmaceutical company, which develops vaccines for infectious d...

News

StockNews.com Begins Coverage on VBI Vaccines (NASDAQ:VBIV)

Zolmax Stock analysts at StockNews.com initiated coverage on shares of VBI Vaccines (NASDAQ:VBIV - Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a "sell...\n more…

Why Is VBI Vaccines (VBIV) Stock Up 62% Today?

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nVBI Vaccines stock is up on Tuesday as shares of VBIV continue to be volatile after the company filed for bankruptcy last week.\nThe post...\n more…

VBI Vaccines provides restructuring proceedings update

Seeking Alpha - Healthcare VBI Vaccines provides restructuring proceedings update...\n more…

VBI Vaccines provides update on restructuring proceedings, to delist shares

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

VBI Vaccines Provides an Update on its Restructuring Proceedings

Business Wire VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided an update on the restructuring...\n more…

VBI Vaccines (NASDAQ:VBIV) Now Covered by Analysts at StockNews.com

Ticker Report StockNews.com started coverage on shares of VBI Vaccines (NASDAQ:VBIV - Free Report) in a report published on Wednesday morning. The brokerage issued a sell rating on the biopharmaceutical company's...\n more…